Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?
- PMID: 7707102
- DOI: 10.1200/JCO.1995.13.4.1044
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?
Comment on
-
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.J Clin Oncol. 1994 Oct;12(10):2078-85. doi: 10.1200/JCO.1994.12.10.2078. J Clin Oncol. 1994. PMID: 7931477 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
